Dr. Megan H. Hyland, MD, MS, is an Assistant Professor at the University of Rochester Medical Center. Dr. Hyland graduated from Rensselaer Polytechnic Institute with a degree in biomedical engineering and worked as a reliability engineer prior to attending medical school. She completed her medical degree, medicine internship and neurology residency at the University of Rochester, followed by a fellowship in Neuroimmunology at the Cleveland Clinic. She simultaneously received her Masters Degree in Clinical Investigation through Case Western Reserve University.
Dr. Hyland returned to Rochester in 2012 after fellowship completion and became co-Medical Director of the Rochester Multiple Sclerosis Center in 2014. In that role, she is passionate about improving access to specialized comprehensive care for patients with multiple sclerosis and similar diseases, such as neuromyelitis optica, neurosarcoidosis, and autoimmune encephalitis. Dr. Hyland is also the co-chair of the Clinical Advisory Committee for the Upstate New York Chapter of the National MS Society.
Dr. Hyland is involved in several clinical trials investigating multiple sclerosis therapies--both symptomatic treatments and therapies designed to slow or halt disease progression. She is evaluating the use of telemedicine as an alternate means of providing care to MS patients. Her research interests also include epidemiological studies in MS and analysis of large patient databases to answer clinical questions not easily assessed through clinical trials.